Skip to content
Axe Capital logo Axe Capital Trading News

Should You Buy Markel Stock (MKL) on the Dip?

2026-10-27 02:25 •Selena Maranjian •The Motley Fool Negative Axe Cap view: Selective •Equities•Earnings•Capital Returns •MKL•BRK.A•BRK.B

Axe Cap view

Markel’s Dip: A Cautionary Tale for JSE Investors

Markel’s recent share drop raises questions, but local investors should tread carefully given its vulnerabilities and lack of dividends.

Markel has earned its ‘mini-Berkshire’ nickname through decades of beating the S&P 500, but the recent 13% drop in share price underlines some cracks. Their insurance underwriting has been weak, while swings in the stock market bite harder since a big chunk of their capital sits in equities. For South African investors used to companies like Sanlam or Old Mutual, Markel’s approach looks aggressive and risky, especially when it doesn’t return cash via dividends. The local rand may move subtly if USD/ZAR shifts with global risk sentiment, but Markel itself is best viewed as a US-focused play with indirect impact here. If you want exposure to insurance-linked equities on the JSE, wait for clearer signs of underwriting stability and dividend signals. Markel’s fair valuation today ignores these headwinds, so patience wins. If global markets regain strength quickly, Markel could recover sooner, but that remains speculative. this is just our opinion and not financial advice

How I would invest

Watch Markel for now. Prefer South African insurers with consistent underwriting and dividends like Sanlam over uncertain US counterparts. Stay alert to USD/ZAR moves that influence multinational earnings.

What I would watch
  • MKL
  • USD/ZAR
  • Sanlam
What could go wrong
  • continued weak underwriting results at Markel
  • volatility in global equity markets
  • unexpected strengthening of USD against ZAR impacting local valuations
How strongly I feel

6/10

Markel shares are down 13% year-to-date, prompting questions about whether it's a good buying opportunity. While the 'mini-Berkshire' has historically outperformed the S&P 500 (10.9% vs 8.7% annually over 30 years), recent performance has been underwhelming. The author advises caution due to poor underwriting results, vulnerability to stock market swings through its large stock portfolio, and lack of dividend payments.

Our take is based on reporting first published by The Motley Fool.

Read the original story